Treatment for Antipsychotic-Induced Tardive Dyskinesia: New Insights

Tardive dyskinesia, an involuntary athetoid or choreiform movements, generally of the tongue, lower face and jaw, and extremities, is highly prevalent in patients with schizophrenia after long-term antipsychotic use. What about clozapine for TD?

Related Videos
Related Content

Is Clozapine-Induced Weight Gain Dose-Dependent?

March 27th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

Evenamide for Treatment-Resistant Schizophrenia

March 23rd 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021

Sleep Disturbances in Individuals at Ultra-High Risk of Psychosis

March 16th 2023

Prisoner of the Brain: Recognizing the Serious Implications of Catatonia

March 16th 2023

Is Clozapine-Induced Weight Gain Dose-Dependent?

March 27th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

Evenamide for Treatment-Resistant Schizophrenia

March 23rd 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021

Sleep Disturbances in Individuals at Ultra-High Risk of Psychosis

March 16th 2023

Prisoner of the Brain: Recognizing the Serious Implications of Catatonia

March 16th 2023

Is Clozapine-Induced Weight Gain Dose-Dependent?

March 27th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

Evenamide for Treatment-Resistant Schizophrenia

March 23rd 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021

Sleep Disturbances in Individuals at Ultra-High Risk of Psychosis

March 16th 2023

Prisoner of the Brain: Recognizing the Serious Implications of Catatonia

March 16th 2023
© 2023 MJH Life Sciences

All rights reserved.